ATI Pathophysiology Test Bank Related

Review ATI Pathophysiology Test Bank related questions and content

In osteoporosis, what is the expected therapeutic action of raloxifene (Evista)?

  • A. It decreases bone resorption and increases bone density.
  • B. It stimulates the formation of new bone.
  • C. It increases calcium absorption in the intestines.
  • D. It decreases the excretion of calcium through the kidneys.
Correct Answer: A

Rationale: The correct answer is A. Raloxifene works by decreasing bone resorption and increasing bone density. This helps in strengthening bones, reducing the risk of fractures, and improving bone health in patients with osteoporosis. Choice B is incorrect because raloxifene does not directly stimulate the formation of new bone but rather prevents bone loss. Choice C is incorrect as raloxifene does not primarily affect calcium absorption in the intestines. Choice D is also incorrect as raloxifene does not primarily decrease the excretion of calcium through the kidneys.